Susan Hasty, Publisher
Table of Contents . . . February 24th, 2003
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Bioterrorism Week | Other Publications
Environmental Toxins - FDA encourages NDAs for Prussian blue as treatment for radiation poisoning
Smallpox - Protection project launched to counter bioterrorism
Nerve Gas - FDA approves pyridostigmine bromide as pretreatment
Smallpox - Computers worldwide speed search for drugs
Vaccine Development - CEL-1000 is a potential agent against bioterrorism
Bacteriology - Paladin Capital invests $10.5M in AgION
Bioinformatics - SBIR contract granted to continue development of system for DOD
Biological Pathogens - President's vaccine funding announcement gets positive reception
Blood Supply - Bonfils selected to provide blood to the military
Food Supply - FDA must refocus proposed rules on prior notice, NFPA says
Food-borne Illness - WHO urges government to act against terror risk to food
Malaria - R&D agreement with U.S. Navy signed for vaccine development
Smallpox - Concerns about compensation for injuries hamper inoculation program
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.